AJAC  Vol.3 No.12 , December 2012
Effect of Cyclodextrin Complexation on the Aqueous Solubility of Diazepam and Nitrazepam: Phase-Solubility Analysis, Thermodynamic Properties
Abstract: The solubility enhancement of diazepam and nitrazepam in water was analyzed depending on temperature and amount of α-cyclodextrin ( α-CD), β-cyclodextrin (β-CD) and 2-hydroxypropyl-β-cyclodextrin (2-HP-β-CD). The interactions of drug-cyclodextrin in solution were investigated by the phase-solubility analysis. Diazepam (nitrazepam) content in aqueous complexation medium was analyzed UV spectrophotometrically. Classical solubility data were used to derive apparent stability constants (K1:1) which were used to derive thermodynamic parameters for the diazepam (nitrazepam)-cyclodextrin complexes. Since all phase solubility plots were of AL–types, and calculated Slopes after linear regression analysis were found to be less than 1, it could be assumed that stoichiometry of the formed binary systems was 1:1. According to the calculated K1:1 values, the stability of the complexes of diazepam and nitrazepam with a-CD, β-CD and 2-HP-β-CD varies as follows: 2-HP-β-CD > β-CD > β-CD. The a-CD has higher affinity for dissolving nitrazepam compared to diazepam. While all parameters lead to an improvement in solubility, the largest effect was obtained for guest-host complexation with 2-HP-β-CD. The solubility of diazepam and nitrazepam in water increased 93.02 times and 64.23 times, respectively, in the presence of 40% (w/w) 2-HP-β-CD, at 25°C. Solubility data for diazepam and nitrazepam in aqueous 2-HP-b-CD were used to derive thermodynamic parameters, ΔG° at 298 K = –14.43 kJ·mol–1, ΔH° = 0.79 kJ·mol–1, ΔS° at 298 K = 51.17 J·mol–1·K–1 and ΔG° at 298 K = –13.43 kJ·mol–1, ΔH° = 2.38 kJ·mol–1, ΔS° at 298 K = 53.01 J·mol–1·K–1, respectively. Formation of inclusion complexes substantially increases the water solubility of diazepam and nitrazepam. Diazepam and nitrazepam dissolution thermodynamics in aqueous 2-HP-β-CD were characterized by spontaneous and endothermic dissolution and hydrophobic interactions.
Cite this paper: J. Hadžiabdić, A. Elezović, O. Rahić and I. Mujezin, "Effect of Cyclodextrin Complexation on the Aqueous Solubility of Diazepam and Nitrazepam: Phase-Solubility Analysis, Thermodynamic Properties," American Journal of Analytical Chemistry, Vol. 3 No. 12, 2012, pp. 811-819. doi: 10.4236/ajac.2012.312107.

[1]   H. Mohler, M. J. Fritschy and U. Rudolph, “A New Benzodiazepine Pharmacology,” The Journal of Pharmacology and Experimental Therapeutics, Vol. 300, No. 1, 2002, pp. 2-8.

[2]   J. Hadziabdic and S. Hadzovic, “Influence of Particle Size on Water Solubility of Almost Insoluble Benzo-diazepines,” Pharmacia, No. 16, 2005-2006, pp. 35-39.

[3]   R. Arun, K. C. K. Ashok and V. V. N. S. S. Sravanthi, “Cyclodextrins as Drug CarrierMolecule: A Review,” Scientia Pharmaceutica, Vol. 76, No. 4, 2008, pp. 567-598. doi:10.3797/scipharm.0808-05

[4]   M. E. Brewster and T. Loftsson, “Cyclodextrins as Pharmaceutical Solubilizers,” Advenced Drug Delivery Reviews, Vol. 59, No. 7, 2007, pp. 645-666. doi:10.1016/j.addr.2007.05.012

[5]   M. Jug and M. B. La?an, “Cyclodextrin-Based Pharmaceuticals,” Rad. MedicalSciences, Vol. 32, No. 499, 2008, pp. 9-26.

[6]   T. Higuchi and A. K. Connors, “Phase Solubility Techniques,” In: C.N. Reilly, Ed., Advences in Analytical Chemistry and Instrumentation, Vol. 4, Wiley-Interscience, New York, 1965, pp. 117-212.

[7]   C. T. Klein, D. Polheim, H. Viernstein, P. Wolschann, “A Method for Prediction of the Free Energies of Complexation between Cyclodextrin and Guest Molecules,” Journal of Inclusion Phenomena and Macrocyclic Chemistry, Vol. 36, No. 4, 2000, pp. 409-423. doi:10.1023/A:1008063412529

[8]   Council of Europe, “The European Pharmacopoeia,” 3rd Edition, Vol. 2, European Directorate for the Quality of Medicine (EDQM), Strasbourg, 1997, pp. 729-730.

[9]   T. Loftsson, D. Hreinsdóttir and M. Másson, “The Complexation Efficiency,” Journal of Inclusion Phenomena and Macrocyclic Chemistry, Vol. 57, No. 1-4, 2007, pp. 545-552. doi:10.1007/s10847-006-9247-2

[10]   J. H. Beijnen, S. C. van der Schoot, B. Nuijen, F. M. Flesch, A. Gore, D. Mirejovskyand and L. Lenaz, “Complexation Study of the Anticancer Agent EO-9 with 2-Hydroxypropyl-Beta-Cyclodextrin,” Drug Development and Industrial Pharmacy, Vol. 34, No. 10, 2008, pp. 1130-1139. doi:10.1080/03639040801974261

[11]   A. H. Al-Marzouqi, I. Shehatta, B. Jobe and A. Dowaidar, “Phase Solubility and Inclusion Complex of Itraconazole with β-Cyclodextrin Using Supercritical Carbon Dioxide,” Journal of Pharmaceutical Sciences, Vol. 95, No. 2, 2006, pp. 292-304. doi:10.1002/jps.20535

[12]   P. J. Sinko, “Martin’s Physical Pharmacy and Pharmaceutical Sciences,” 5th Edition, Lippincott Williams & Wilkins, Philadelphia, 2006, pp. 72-80.

[13]   K. A. Connors, “Thermodynamics of Pharmaceutical Systems: An Introduction for Students of Pharmacy,” John Wiley & Sons, Inc., Hoboken, 2002, pp. 52-55. doi:10.1002/0471234923.ch4

[14]   C. Akbay, L. N. Gill and M. I. Warner, “Thermodynamic Studies of the Interaction of Molecular Micelles and Copolymerized Molecular Micelles with Benzodiazepinesand Alkyl Phenyl Ketones Using MEKC,” Electrophoresis, Vol. 28, No. 11, 2007, pp. 1752-1761. doi:10.1002/elps.200600449